UNH
UnitedHealth Group Incorporated · Healthcare · Medical - Healthcare Plans
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 2.72M | $992.18M | n/a | n/a |
| Q2 2026 | 189 | +4 | 633.24M | $262.15B | +9 | −7 |
| Q1 2026 | 190 | -6 | 606.80M | $164.36B | +1 | −8 |
| Q4 2025 | 195 | +3 | 637.54M | $210.43B | +4 | n/a |
| Q3 2025 | 33 | -2 | 387.11M | $133.65B | +1 | −4 |
| Q2 2025 | 33 | +4 | 360.68M | $112.49B | +5 | −1 |
| Q1 2025 | 26 | -2 | 169.46M | $88.72B | n/a | −2 |
| Q4 2024 | 28 | +3 | 163.08M | $82.47B | +4 | −1 |
| Q3 2024 | 24 | -5 | 123.39M | $72.10B | n/a | −5 |
| Q2 2024 | 29 | n/a | 129.84M | $66.09B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 28.02M | n/a | $14.27B | 2.3% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 26.02M | n/a | $13.25B | 1.6% | n/c | 1 | SEC ↗ ×2 |
| 3 | Wellington Management ✦ | 25.88M | n/a | $13.18B | 2.4% | n/c | 1 | SEC ↗ ×9 |
| 4 | Geode Capital Management ✦ (passive) | 19.32M | n/a | $9.81B | 0.9% | n/c | 1 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passive) | 11.71M | n/a | $5.96B | 0.9% | n/c | 1 | SEC ↗ |
| 6 | Dodge & Cox ✦ | 3.92M | n/a | $2.00B | 1.2% | n/c | 1 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 3.09M | n/a | $1.57B | 0.7% | n/c | 1 | SEC ↗ |
| 8 | Tiger Global Management ✦ | 2.35M | n/a | $1.20B | 5.5% | n/c | 1 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 1.83M | n/a | $930.09M | 0.8% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.22M | n/a | $622.52M | 0.5% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.02M | n/a | $519.75M | 0.8% | n/c | 1 | SEC ↗ ×2 |
| 12 | Adage Capital Partners ✦ | 959.07K | n/a | $488.42M | 0.9% | n/c | 1 | SEC ↗ |
| 13 | Lone Pine Capital ✦ | 944.32K | n/a | $480.90M | 3.9% | n/c | 1 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 894.01K | n/a | $455.28M | 0.4% | n/c | 1 | SEC ↗ ×4 |
| 15 | Citadel Advisors ✦ | 765.08K | n/a | $389.62M | 0.4% | n/c | 1 | SEC ↗ ×2 |
| 16 | Viking Global Investors ✦ | 441.80K | n/a | $224.99M | 0.9% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 360.86K | n/a | $183.77M | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 18 | Point72 Asset Management ✦ | 272.06K | n/a | $138.55M | 0.5% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 276.27K | n/a | $136.94M | 0.2% | n/c | 1 | SEC ↗ ×4 |
| 20 | Appaloosa ✦ | 185.00K | n/a | $94.21M | 1.5% | n/c | 1 | SEC ↗ |
| 21 | PRIMECAP Management ✦ | 116.46K | n/a | $59.31M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Coatue Management ✦ | 97.44K | n/a | $49.62M | 0.2% | n/c | 1 | SEC ↗ ×4 |
| 23 | Renaissance Technologies ✦ | 71.33K | n/a | $36.32M | 0.1% | n/c | 1 | SEC ↗ |
| 24 | Soros Fund Management ✦ | 25.00K | n/a | $12.73M | 0.4% | n/c | 1 | SEC ↗ |
| 25 | Markel Group ✦ | 20.81K | n/a | $10.60M | 0.1% | n/c | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 12.62K | n/a | $6.42M | 0.1% | n/c | 1 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 6.35K | n/a | $3.24M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | GAMCO Investors ✦ | 3.45K | n/a | $1.76M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Harris Associates (Oakmark) ✦ | 420 | n/a | $213,889 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 3,004 holders, 728.55M shares, $187.05B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.17K sh · $455,910
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology